Clinical Role - Specialty Pharmacy
Pharmacy Times® is a leader in providing expert insights and clinical updates to specialty pharmacists and reaches more than 200,000 pharmacy professionals in total.
A blood-based screening test using cell-free DNA may be able to identify cancer at earlier stages than what was previously possible, according to research to be presented at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium, held January 23 to 25 in San Francisco.
Top news of the day from across the health care landscape.
Top news of the week from Specialty Pharmacy Times.
Tazemetostat blocks any activity of the EZH2 methyltransferase, which may help keep the cancer cells from further growth.
Pharmacies are using technology not only to offer safe filling, but generate greater engagement with their customer base.
Pfizer will become the first to launch 3 oncology monoclonal antibody biosimilar treatments to the US market.
The study was the first to examine proton pump inhibitors use in breast cancer survivors.
Top news of the day from across the health care landscape.
An introduction to practice pearl #1 with identifying severity of disease, and determining goals of therapy.
A proposed FDA guidance could significantly impact veterinary practices and their ability to compound medicines for animal patients, according to a national survey.1
Valoctocogene roxaparvovec (Valrox, BioMarin Pharmaceutical Inc) would be the first gene therapy in the United States for the most common form of hemophilia if approved by the FDA.1
Biosimilars, which at the most simplistic level can be thought of as a type of generic option for a biologic, offer an opportunity to help reduce total biologic drug spend.